Second Time a Charm as House Approves Bill to Federally Legalize Cannabis – Hemp, Inc. Reports

Las Vegas, NV, April 04, 2022 (GLOBE NEWSWIRE) -- via  Hemp, Inc. (OTC PINK: HEMP) reports today that the U.S. House of Representatives approved the bill, on Friday, April 1, 2022, to federally legalize marijuana. Under the , cannabis would be removed from the list of drugs regulated by the Controlled Substances Act, criminal penalties for federal cannabis offenses would be eliminated, and past federal cannabis convictions would be expunged.   (the MORE Act) will now advance to the Senate floor to be voted on, debated or amended.

According to , “the vote fell largely along party lines with only three Republicans supporting the measure and two Democrats opposing it. Following an hour of debate on the Marijuana Opportunity, Reinvestment and Expungement (MORE) Act from House Judiciary Chairman Jerrold Nadler (D-NY)—and the approval of two amendments and the rejection of a third—the full chamber  220-204 to end federal cannabis prohibition and promote social equity in the industry.”

Hopefuls are optimistic that the second time around will be a charm with a Senate approval. The  was approved by the House of Representatives in December 2020, but the bill was not given a hearing or a vote in the Senate.  According to , when the MORE Act went to the floor 2 years ago, it passed in a 228-164 vote, with five Republicans joining their Democratic colleagues in advancing the reform. Now that it has passed the House, the MORE Act will need 60 votes to pass the Senate.

As Hemp, Inc. reported last week, de-scheduling news of this magnitude has shown to peak cannabis stock market prices and trading volume. Cannabis has been a Schedule 1 Controlled Substance for the past 52 years. According to , “cannabis is legal for adult use in 19 states and for medical use in 36 states. This bill would end the federal ban, but leave legalization up to the states.” reports, “The global cannabis market is projected to grow from $28.266 billion in 2021 to $197.74 billion in 2028.”

Hemp, Inc. released two of its most highly potent powerhouse products to date. On March 22, 2022, Hemp, Inc.  a tincture with 4 times the potency of most other hemp-derived tinctures currently in the market and at a fraction of the price.  Two days later, the Company  a CBD/CBG high potency blend in capsule form and offered free sample packs (plus shipping and handling) to the first 100 customers who ordered it from the King of Hemp website. 

Hemp, Inc.’s King of Hemp® premium power-packed capsules promote enhanced mood and clarity with rejuvenating properties.  Some users have reported feeling rejuvenated, stress-free and tension-free. All of the King of Hemp® products, including the capsules, are independently tested by a third-party lab and manufactured in the USA at Hemp, Inc.’s manufacturing facility in Nevada. Our products are 100% sustainably sourced, offer premium vegan grade, gluten-free, non-psychoactive and have been through proven compliant testing for microbials, heavy metals, pesticides, and dangerous chemicals.

For more information on the free sample pack offer, with $7.95 shipping and handling, visit the  Kingofhempusa.com.  Retailers and distributors interested in the product line should email  . Shareholders and consumers who want to purchase products can click  and use discount code “PRBP8967” for a 10% discount.

Hemp, Inc.’s sales & marketing team is currently working on large-scale orders for the company’s upcoming CBDA and CBGA products. Small retail stores or those interested in distributing on a large-scale basis should email   or call 877-436-7564 for more information. The entire product line may include infused water, tinctures, gummies, capsules, edibles and more. They’ll come in a variety of sizes, potencies, flavors and formulas that executives foresee being in high demand.

FORWARD-LOOKING DISCLAIMER AND DISCLOSURES

This press release may contain certain forward-looking statements and information, as defined within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934 and is subject to the Safe Harbor created by those sections. The Securities and Exchange Commission (SEC) requires issuers to provide “adequate current information”. Financials for Hemp, Inc. are listed on the OTC Exchange. More information can also be found out the Hemp, Inc. website by visiting . Material contains statements about expected future events and/or financial results that are forward-looking in nature and subject to risks and uncertainties. Such forward-looking statements involve risks, uncertainties.

Contact:

Hemp, Inc.

Investor Relations: 855-436-7688

Sales: 877-436-7564